A morphologic study of retinal toxicity induced by triamcinolone acetonide vehicles in rabbit eyes

Retina

Volumn 28, Issue 3, 2008, Pages 504-510

  Li, Qian ^a   Wang, Jingzhao ^a   Yang, Lin ^a   Mo, Bin ^a   Zeng, Huiyang ^b   Wang, Ningli ^a   Liu, Wu ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Intravitreal injection; Rabbit; Retinal toxicity; Triamcinolone acetonide vehicle

Indexed keywords

TRIAMCINOLONE ACETONIDE; ACETIC ACID DERIVATIVE; BENZYL ALCOHOL; BSS SOLUTION; CARBOXYMETHYLCELLULOSE; DRUG VEHICLE; MINERAL; POLYSORBATE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EYE TOXICITY; MICROSCOPY; MORPHOLOGICAL TRAIT; NONHUMAN; OPHTHALMOSCOPE; RETINA BIPOLAR GANGLION CELL; RETINA EDEMA; RETINA HEMORRHAGE; RETINA INJURY; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG COMBINATION; DRUG EFFECT; INJECTION; RABBIT; RETINA; RETINA DISEASE; ULTRASTRUCTURE; VEHICLES; VITREOUS BODY;

ACETATES; ANIMALS; BENZYL ALCOHOL; CARBOXYMETHYLCELLULOSE; DRUG COMBINATIONS; INJECTIONS; MINERALS; POLYSORBATES; RABBITS; RETINA; RETINAL DISEASES; SODIUM CHLORIDE; TRIAMCINOLONE ACETONIDE; VEHICLES; VITREOUS BODY;

EID: 40449083620     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318158e9c0     Document Type: Article

References (38)

1. Antcliff RJ, Spalton DJ, Stanford MR, et al. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-772.
2. Greenberg PB, Martidis A, Rogers AH, et al. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-248.
3. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 2001;132:425-427.
4. Martidis A, Duker JS, Puliafito CA. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 2001;119:1380-1383.
5. Young S, Larkin G, Branley M, Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001;29:2-6.
6. Jonas JB, Kreissig I, Degenring RF. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol 2003;136:384-386.
7. Jonas JB, Kreissig I, Hugger P, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-468.
8. Degenring RF, Jonas JB. Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. Br J Ophthalmol 2003;87:361.
9. Jonas JB. Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia. Am J Ophthalmol 2004;137:367-368.
10. Jonas JB, Hayler JK, Söfker A, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001;131:468-471.
11. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy Br J Ophthalmol 2000;84:1064-1067.
12. Schlaegel TF Jr, Wilson FM. Accidental intraocular injection of depot corticosteroids. Trans Am Acad Ophthalmol Otolaryngol 1978;78:847.
13. Roth DB, Chieh J, Spirn MJ, et al. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection. Arch Ophthalmol 2003;121:1279-1282.
14. Sharma MC, Lai WW, Shapiro MJ. Pseudohypopyon following intravitreal triamcinolone acetonide injection. Cornea 2004;23:398-399.
15. Moshfeghi AA, Scott IU, Flynn HW Jr, Puliafito CA. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Am J Ophthalmol 2004;138:489-492.
16. de Campos VE, Maia A, Muccioli C, Belfort R Jr. Pseudohypopyon immediately after intravitreal injection of triamcinolone acetonide - Case reports. Arq Bras Oftalmol 2005;68:251-252.
17. Sutter FKP, Gillies MC. Pseudo-endophthalmitis after intravitreal injection of triamcinolone. Br J Ophthalmol 2003;87:972-974.
18. Chen SD, Lochhead J, McDonald B, Patel CK. Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema. Br J Ophthalmol 2004;88:843-844.
19. Nishimura A, Kobayashi A, Segawa Y, et al. Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter. Retina 2003;23:777-779.
20. Wang K, Jiang Y, Li X. Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density. Graefes Arch Clin Exp Ophthalmol 2006;2:1-8.
21. Gershanik JJ, Boecler B, George W, et al. The grasping syndrome. Benzyl alcohol(BA) poisoning? Clin Res 1981;29:895A.
22. Brown WJ, Buist NRM, Gipson HTC, et al. Fetal benzyl alcohol poisoning in a neonatal intensive care unit. Lancet 1982;1:1250.
23. Benzyl alcohol may be toxic to newborns. FDA Drug Bull 1982;12:10-11.
24. Yeung CK, Chan KP, Chiang SWY, et al. The toxic and stress responses of cultured human retinal pigment epithelium (ARPE19) and human glial cells (SVG) in the presence of triamcinolone. Invest Ophthalmol Vis Sci 2003;44:5293-5300.
25. Yeung CK, Chan KP, Chan CK, et al. Cytotoxicity of triamcinolone on cultured human retinal pigment epithelial cells: comparison with dexamethasone and hydrocortisone. Jpn J Ophthalmol 2004;48:236-242.
26. Szurman P, Kaczmarek R, Spitzer MS, et al. Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells. Experimental Eye Research 2006;83:584-592.
27. Shaikh S, Ho S, Engelmann LA, Klemann SW. Cell viability effects of triamcinolone acetonide and preservative vehicle formulations. Br J Ophthalmol 2006;90:233-236.
28. Narayanan R, Mungcal JK, Kenney MC, et al. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci 2006;47:722-728.
29. Dierks D, Lei B, Zhang K, Hainsworth DP. Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina. Arch Ophthalmol 2005;123:1563-1569.
30. Yu S-Y, Damico FM, Viola F, et al. Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 2006;26:531-536.
31. Hida T, Chandler D, Arena JE, Machemer R. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986;101:190-195.
32. Kozak I, Cheng L, Mendez T, et al. Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit. Retina 2006;26:811-817.
33. Albini TA, Abd-El-Barr MM, Carvounis PE, et al. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes. Invest Ophthalmol Vis Sci 2007;48:390-395.
34. Morrison VL, Koh HJ, Cheng L, et al. Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits. Retina 2006;26:339-344.
35. García-Arumí J, Boixadera A, Giralt J, et al. Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use. Br J Ophthalmol 2005;89:1112-1114.
36. Hernaez-Ortega MC, Soto-Pedre E. A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection. Ophthalmic Surg Lasers Imaging 2004;35:350-351.
37. Kumagai K. Introduction of a new method for the preparation of triamcinolone acetonide solution as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2003;23:881-882.
38. Spandau UHM, Derse M, Schmitz-Valckenberg P, et al. Triamcinolone acetonide concentration after filtration of the solvent agent. Am J Ophthalmol 2005;139:712-713.